Paul LeBon

Articles by Paul LeBon

Latest Updated Articles

Trending on PharmExec

Roundup: TRexBio & Retension Pharmaceuticals Announce IPO Pricing

FDA Approves Tecentriq for Stage III dMMR Colon Cancer

The Most Important Lessons Learned from Building CGT Supply Chains: LogiPharma 2026

Viatris Acquires Pacira BioSciences for $1.65 Billion

Ultragenyx to Sell Rare Pediatric Disease Priority Review Voucher for $210 Million